216 related articles for article (PubMed ID: 25518709)
21. Variation in Human Cytochrome P-450 Drug-Metabolism Genes: A Gateway to the Understanding of Plasmodium vivax Relapses.
Silvino AC; Costa GL; Araújo FC; Ascher DB; Pires DE; Fontes CJ; Carvalho LH; Brito CF; Sousa TN
PLoS One; 2016; 11(7):e0160172. PubMed ID: 27467145
[TBL] [Abstract][Full Text] [Related]
22. Quantitative determination of primaquine-5,6-ortho-quinone and carboxyprimaquine-5,6-ortho-quinone in human erythrocytes by UHPLC-MS/MS.
Khan W; Wang YH; Nanayakkara NPD; Herath HMTB; Catchings Z; Khan S; Fasinu PS; ElSohly MA; McChesney JD; Khan IA; Chaurasiya ND; Tekwani BL; Walker LA
J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Jan; 1163():122510. PubMed ID: 33387859
[TBL] [Abstract][Full Text] [Related]
23. Cytochrome P(450)-dependent toxic effects of primaquine on human erythrocytes.
Ganesan S; Tekwani BL; Sahu R; Tripathi LM; Walker LA
Toxicol Appl Pharmacol; 2009 Nov; 241(1):14-22. PubMed ID: 19616568
[TBL] [Abstract][Full Text] [Related]
24. Impact of Plasmodium vivax malaria and antimalarial treatment on cytochrome P450 activity in Brazilian patients.
Almeida AC; Elias ABR; Marques MP; de Melo GC; da Costa AG; Figueiredo EFG; Brasil LW; Rodrigues-Soares F; Monteiro WM; de Lacerda MVG; Lanchote VL; Suarez-Kurtz G
Br J Clin Pharmacol; 2021 Apr; 87(4):1859-1868. PubMed ID: 32997351
[TBL] [Abstract][Full Text] [Related]
25. An LC-MS based study of the metabolic profile of primaquine, an 8-aminoquinoline antiparasitic drug, with an in vitro primary human hepatocyte culture model.
Jin X; Pybus BS; Marcsisin R; Logan T; Luong TL; Sousa J; Matlock N; Collazo V; Asher C; Carroll D; Olmeda R; Walker LA; Kozar MP; Melendez V
Eur J Drug Metab Pharmacokinet; 2014 Jun; 39(2):139-46. PubMed ID: 23797843
[TBL] [Abstract][Full Text] [Related]
26. Targeting primaquine into liver using chylomicron emulsions for potential vivax malaria therapy.
Dierling AM; Cui Z
Int J Pharm; 2005 Oct; 303(1-2):143-52. PubMed ID: 16140485
[TBL] [Abstract][Full Text] [Related]
27. Quantitative analysis of primaquine and its metabolites in human urine using liquid chromatography coupled with tandem mass spectrometry.
Khan W; Wang YH; Dhammika Nanayakkara NP; Bandara Herath HMT; Chaurasiya ND; Tekwani BL; ElSohly MA; McChesney JD; Khan IA; Walker LA
J Chromatogr B Analyt Technol Biomed Life Sci; 2022 Dec; 1213():123517. PubMed ID: 36343612
[TBL] [Abstract][Full Text] [Related]
28. Functional characterization of 50 CYP2D6 allelic variants by assessing primaquine 5-hydroxylation.
Saito T; Gutiérrez Rico EM; Kikuchi A; Kaneko A; Kumondai M; Akai F; Saigusa D; Oda A; Hirasawa N; Hiratsuka M
Drug Metab Pharmacokinet; 2018 Dec; 33(6):250-257. PubMed ID: 30366777
[TBL] [Abstract][Full Text] [Related]
29. Susceptibility of glucose-6-phosphate dehydrogenase deficient red cells to primaquine, primaquine enantiomers, and its two putative metabolites. II. Effect on red blood cell membrane, lipid peroxidation, MC-540 staining, and scanning electron microscopic studies.
Agarwal S; Gupta UR; Daniel CS; Gupta RC; Anand N; Agarwal SS
Biochem Pharmacol; 1991 Jan; 41(1):17-21. PubMed ID: 1986741
[TBL] [Abstract][Full Text] [Related]
30. Influence of CYP2D6 genotype on the disposition of the enantiomers of venlafaxine and its major metabolites in postmortem femoral blood.
Kingbäck M; Karlsson L; Zackrisson AL; Carlsson B; Josefsson M; Bengtsson F; Ahlner J; Kugelberg FC
Forensic Sci Int; 2012 Jan; 214(1-3):124-34. PubMed ID: 21840145
[TBL] [Abstract][Full Text] [Related]
31. Differential CYP 2D6 metabolism alters primaquine pharmacokinetics.
Potter BM; Xie LH; Vuong C; Zhang J; Zhang P; Duan D; Luong TL; Bandara Herath HM; Dhammika Nanayakkara NP; Tekwani BL; Walker LA; Nolan CK; Sciotti RJ; Zottig VE; Smith PL; Paris RM; Read LT; Li Q; Pybus BS; Sousa JC; Reichard GA; Marcsisin SR
Antimicrob Agents Chemother; 2015 Apr; 59(4):2380-7. PubMed ID: 25645856
[TBL] [Abstract][Full Text] [Related]
32. Primaquine pharmacology in the context of CYP 2D6 pharmacogenomics: Current state of the art.
Marcsisin SR; Reichard G; Pybus BS
Pharmacol Ther; 2016 May; 161():1-10. PubMed ID: 27016470
[TBL] [Abstract][Full Text] [Related]
33. Cytochrome P450 2D6 profiles and their relationship with outcomes of primaquine anti-relapse therapy in Australian Defence Force personnel deployed to Papua New Guinea and East Timor.
Chen N; Dowd S; Gatton ML; Auliff A; Edstein MD; Cheng Q
Malar J; 2019 Apr; 18(1):140. PubMed ID: 30999967
[TBL] [Abstract][Full Text] [Related]
34. Effects of MAO-A and CYP450 on primaquine metabolism in healthy volunteers.
Ariffin NM; Islahudin F; Kumolosasi E; Makmor-Bakry M
Parasitol Res; 2019 Mar; 118(3):1011-1018. PubMed ID: 30706164
[TBL] [Abstract][Full Text] [Related]
35. Comparison of enzyme kinetics of warfarin analyzed by LC-MS/MS QTrap and differential mobility spectrometry.
Shaik AN; Grater R; Lulla M; Williams DA; Gan LL; Bohnert T; LeDuc BW
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Jan; 1008():164-173. PubMed ID: 26655108
[TBL] [Abstract][Full Text] [Related]
36. Comparison of catalytical activity and stereoselectivity between the recombinant human cytochrome P450 2D6.1 and 2D6.10.
Kong LM; Qian MR; Hu HH; Xu SY; Yu LS; Jiang HD; Chen SQ; Zeng S
Pharmazie; 2012 May; 67(5):440-7. PubMed ID: 22764579
[TBL] [Abstract][Full Text] [Related]
37. Analysis of primaquine and its metabolite carboxyprimaquine in biological samples: enantiomeric separation, method validation and quantification.
Avula B; Khan SI; Tekwani BL; Nanayakkara NP; McChesney JD; Walker LA; Khan IA
Biomed Chromatogr; 2011 Sep; 25(9):1010-7. PubMed ID: 21058417
[TBL] [Abstract][Full Text] [Related]
38. The conversion of primaquine into primaquine-aldehyde, primaquine-alcohol, and carboxyprimaquine, a major plasma metabolite.
Frischer H; Mellovitz RL; Ahmad T; Nora MV
J Lab Clin Med; 1991 Jun; 117(6):468-76. PubMed ID: 2045714
[TBL] [Abstract][Full Text] [Related]
39. Cytochrome P450 2D-mediated metabolism is not necessary for tafenoquine and primaquine to eradicate the erythrocytic stages of Plasmodium berghei.
Milner EE; Berman J; Caridha D; Dickson SP; Hickman M; Lee PJ; Marcsisin SR; Read LT; Roncal N; Vesely BA; Xie LH; Zhang J; Zhang P; Li Q
Malar J; 2016 Dec; 15(1):588. PubMed ID: 27923405
[TBL] [Abstract][Full Text] [Related]
40. Photoreactivity of biologically active compounds, XIV: influence of oxygen on light induced reactions of primaquine.
Kristensen S; Nord K; Orsteen AL; Tønnesen HH
Pharmazie; 1998 Feb; 53(2):98-103. PubMed ID: 9540107
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
